🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge
Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results

Pragmatic and Observational Research(2020)10.2147/por.s251120Source: DataRank Database

The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results is a research paper published in Pragmatic and Observational Research (2020). On theSindex it has a DataRank of 0.955. It has been cited 25 times, with 11 citing works in its 1-hop citation network.

N/A
0.955DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access25 citations · 11 citing works in its network
Cite:
Data availability

Repositories this paper deposited data in (declared in PubMed).

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring
Enrichment:Pending

FAIR Checklist

Context only (not used in score)
Findable (1/2)
  • Has DOI
Accessible (1/2)
  • Open Access
Interoperable (0/2)
    Reusable (0/3)

      FAIR checklist signals are shown for context only and do not affect DataRank scoring.

      Run a calibrated FAIR evaluation for this paper →

      We only score data papers we can read in full — never from an abstract alone.

      DataRank Breakdown

      Base Score 51%Citation Network 49%

      Base Score Contribution

      0.489

      From this paper's citation signal

      Citation Network Contribution

      0.466

      From 8 citing papers with measurable signal

      Learn more about DataRank methodology →

      Top 5 citers driving the network score

      Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 11 citers.

      1. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
        Journal of Asthma and Allergy2022100 citations21 referencesContributes 0.220
      2. Clinical and economic burden of severe asthma among US patients treated with biologic therapies
        Annals of Allergy Asthma & Immunology202145 citations42 referencesContributes 0.091
      3. Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study
        Journal of Clinical Medicine202433 citations42 referencesContributes 0.084
      4. The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma
        The Korean Journal of Internal Medicine202228 citations66 referencesContributes 0.051
      5. A Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
        Advances in Therapy202222 citations70 referencesContributes 0.045

      Authors (11)

      Bradley E. ChippsORCID,Wendy C. MooreORCID,Weily SoongORCID,Jennifer TrevorORCID,Dennis K. LedfordORCID